Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10202 |
| Vaccine Name | rVSV-EBOV |
| Disease Name | Ebola |
| Disease Classification | Hemorrhagic |
| Virus Name | Zaire ebolavirus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | Merck & Co. Inc. |
| Year of Manufacturing | 2014 |
| Manufacturing Country | USA |
| Age | 18 - 65 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Zaire Ebola virus glycoprotein |
| Description | Vesicular Stomatitis Virus based |
| Approving Organisation | NA |
| Collaborating Organisation | National Institute of Allergy and Infectious Diseases |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 27764560 |
| Clinical Trial ID | NCT02280408 |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ |
| Additional Links | NA |